Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Edwards

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
British Journal of Urology|December 1, 1985
The influence of retinoic acid receptor (RAR) status of bladder tumours on the course of the diseaseA R de Bolla, R M Shave, S L Fagg, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Synthesis and enzymatic evaluation of a P1 arginine aminocoumarin substrate library for trypsin-like serine proteasesP D Edwards, R C Mauger, K M Cottrell, et al.
The Journal of Antibiotics|March 1, 1991
6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. IV. Kidney stability, serum binding and additional biological evaluation of racemic derivativesI S Bennett, N J Broom, K Coleman, et al.
Journal of Medicinal Chemistry|September 30, 1994
Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketonesP R Bernstein, D Andisik, P K Bradley, et al.
Journal of Medicinal Chemistry|April 29, 1994
Design of orally active, non-peptidic inhibitors of human leukocyte elastaseF J Brown, D W Andisik, P R Bernstein, et al.
Journal of Medicinal Chemistry|September 30, 1994
Nonpeptidic inhibitors of human leukocyte elastase. 2. Design, synthesis, and in vitro activity of a series of 3-amino-6-arylopyridin-2-one trifluoromethyl ketonesJ R Damewood, P D Edwards, S Feeney, et al.
Biochemistry|May 19, 1987
Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketonesR L Stein, A M Strimpler, P D Edwards, et al.
Journal of Vascular Surgery|July 1, 1997
Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemiaP J Hess, J M Seeger, T S Huber, et al.
Immunopharmacology|August 11, 2000
C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocyclesS T Furlong, A S Dutta, M M Coath, et al.
Shock (Augusta, Ga.)|September 1, 1996
Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouseM B Welborn, W G Douglas, Z Abouhamze, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Urology|December 1, 1985
The influence of retinoic acid receptor (RAR) status of bladder tumours on the course of the diseaseA R de Bolla, R M Shave, S L Fagg, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Synthesis and enzymatic evaluation of a P1 arginine aminocoumarin substrate library for trypsin-like serine proteasesP D Edwards, R C Mauger, K M Cottrell, et al.
The Journal of Antibiotics|March 1, 1991
6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. IV. Kidney stability, serum binding and additional biological evaluation of racemic derivativesI S Bennett, N J Broom, K Coleman, et al.
Journal of Medicinal Chemistry|September 30, 1994
Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketonesP R Bernstein, D Andisik, P K Bradley, et al.
Journal of Medicinal Chemistry|April 29, 1994
Design of orally active, non-peptidic inhibitors of human leukocyte elastaseF J Brown, D W Andisik, P R Bernstein, et al.
Journal of Medicinal Chemistry|September 30, 1994
Nonpeptidic inhibitors of human leukocyte elastase. 2. Design, synthesis, and in vitro activity of a series of 3-amino-6-arylopyridin-2-one trifluoromethyl ketonesJ R Damewood, P D Edwards, S Feeney, et al.
Biochemistry|May 19, 1987
Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketonesR L Stein, A M Strimpler, P D Edwards, et al.
Journal of Vascular Surgery|July 1, 1997
Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemiaP J Hess, J M Seeger, T S Huber, et al.
Immunopharmacology|August 11, 2000
C3 activation is inhibited by analogs of compstatin but not by serine protease inhibitors or peptidyl alpha-ketoheterocyclesS T Furlong, A S Dutta, M M Coath, et al.
Shock (Augusta, Ga.)|September 1, 1996
Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouseM B Welborn, W G Douglas, Z Abouhamze, et al.
Pageof 5